IL213446A - Anti-tumor factor, method of producing said factor and method of stabilization - Google Patents

Anti-tumor factor, method of producing said factor and method of stabilization

Info

Publication number
IL213446A
IL213446A IL213446A IL21344611A IL213446A IL 213446 A IL213446 A IL 213446A IL 213446 A IL213446 A IL 213446A IL 21344611 A IL21344611 A IL 21344611A IL 213446 A IL213446 A IL 213446A
Authority
IL
Israel
Prior art keywords
dna
solution
fluorouracil
drug
aqueous solution
Prior art date
Application number
IL213446A
Other languages
English (en)
Hebrew (he)
Other versions
IL213446A0 (en
Inventor
Ilima Iliodorovna Volchenskova
Nadezhda Nikolaevna Maydanevich
Original Assignee
Oleg Sergeevich Sokyrko
Ilima Iliodorovna Volchenskova
Nadezhda Nikolaevna Maydanevich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from UAA200906849A external-priority patent/UA90233C2/uk
Application filed by Oleg Sergeevich Sokyrko, Ilima Iliodorovna Volchenskova, Nadezhda Nikolaevna Maydanevich filed Critical Oleg Sergeevich Sokyrko
Publication of IL213446A0 publication Critical patent/IL213446A0/en
Publication of IL213446A publication Critical patent/IL213446A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL213446A 2008-12-22 2011-06-09 Anti-tumor factor, method of producing said factor and method of stabilization IL213446A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
UA200814666 2008-12-22
UAA200906849A UA90233C2 (uk) 2009-06-30 2009-06-30 Спосіб стабілізації протипухлинних засобів на основі водного розчину сполуки платини з дезоксирибонуклеїновою кислотою
PCT/UA2009/000058 WO2010074662A1 (ru) 2008-12-22 2009-11-23 Противоопухолевое средство, способ его получения и способ его стабилизации

Publications (2)

Publication Number Publication Date
IL213446A0 IL213446A0 (en) 2011-07-31
IL213446A true IL213446A (en) 2013-11-28

Family

ID=42288021

Family Applications (1)

Application Number Title Priority Date Filing Date
IL213446A IL213446A (en) 2008-12-22 2011-06-09 Anti-tumor factor, method of producing said factor and method of stabilization

Country Status (8)

Country Link
CN (1) CN102227222B (pt)
BG (1) BG66625B1 (pt)
BR (1) BRPI0923273A2 (pt)
EA (1) EA015680B1 (pt)
IL (1) IL213446A (pt)
PL (1) PL219734B1 (pt)
TR (1) TR201104008T1 (pt)
WO (1) WO2010074662A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102784098A (zh) * 2011-05-20 2012-11-21 湖南省湘中制药有限公司 丙戊酸镁注射液及其制备工艺
CN104937096B (zh) * 2013-01-04 2019-11-05 德克萨斯系统大学董事会 包含柠檬酸的组合物及其应用
CN104027301B (zh) * 2013-03-05 2017-05-10 肖云彩 一种奥拉西坦组合物注射液
RU2667128C2 (ru) 2016-12-29 2018-09-14 Герман Петрович Беккер Композиция для приготовления противоопухолевого средства и способ приготовления противоопухолевого средства на ее основе

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534513A (en) * 1991-09-05 1996-07-09 Taiho Pharmaceutical Company, Ltd. Antitumor potentiator and antitumor composition
UA70455A (en) * 2003-09-23 2004-10-15 Serhii Oleksandrovych Shalimov Antineoplastic platinum drug for topical treatmentantineoplastic platinum drug for topical treatment of oropharyngeal cancer and method for its usage of oropharyngeal cancer and method for its usage
UA70456A (en) * 2003-09-23 2004-10-15 Serhii Oleksandrovych Shalimov Dosage form of infusional antineoplastic drug and dosage form of infusional antineoplastic drug and method for its production method for its production

Also Published As

Publication number Publication date
CN102227222B (zh) 2012-11-21
BG66625B1 (bg) 2017-12-15
TR201104008T1 (tr) 2011-10-21
BG110926A (bg) 2011-10-31
IL213446A0 (en) 2011-07-31
PL394863A1 (pl) 2011-09-26
PL219734B1 (pl) 2015-07-31
EA201100618A1 (ru) 2011-10-31
WO2010074662A1 (ru) 2010-07-01
BRPI0923273A2 (pt) 2014-01-28
EA015680B1 (ru) 2011-10-31
CN102227222A (zh) 2011-10-26

Similar Documents

Publication Publication Date Title
CN101535323A (zh) 唑来膦酸的晶型
IL213446A (en) Anti-tumor factor, method of producing said factor and method of stabilization
US20130296556A1 (en) Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic Acid Ethylamide and Formulations Comprising These Forms
CN101732345A (zh) 顺铂脊柱肿瘤缓释植入剂及其制备方法
RU2461375C1 (ru) Способ комбинированного лечения больных местно-распространенным раком желудка
Singh et al. Design and development of sustained release injectable in situ gel of cytarabine
CN109260201A (zh) 一种吡啶类化合物在制备抗肿瘤药物中的用途
CN104321323A (zh) 碳环核苷及其医药用途和组合物
CN103755695B (zh) 一种具有抗肿瘤活性的酰胺类化合物及其应用
CN102526038A (zh) 替莫唑胺的脑靶向药物组合物及其应用
CN102727909A (zh) 一种抑制原发性肝癌生长和转移的新方法
UA90233C2 (uk) Спосіб стабілізації протипухлинних засобів на основі водного розчину сполуки платини з дезоксирибонуклеїновою кислотою
BRPI0923273B1 (pt) Anitumor agent and methods for production and stabilization
CN106565530B (zh) 一种氨基酸衍生物及其应用
CN1398183A (zh) 含铂络合物化合物的药物和其用途
CN101723906B (zh) 一种化合物、含该化合物的药物组合物及制备方法和用途
CN103772374B (zh) 一种杂环类化合物及其应用
CN104784109A (zh) 紫杉烷类药物的温敏缓释药物组合物
ES2231263T3 (es) Sistemas de liberizacion sostenida de principio activo implantable.
UA86338C2 (uk) Протипухлинний засіб на основі комплексу платини з днк і спосіб його одержання
CN103739615B (zh) 一种具有抗肿瘤活性的酮类化合物及其应用
EP3384900B1 (en) Stable dosage form of etidronate-cytarabine conjugate
CN105541946A (zh) 一种环磷腺苷晶型化合物
CN107837237B (zh) 一种培美曲塞二钠药物组合物及其制备方法
Branter et al. EXTH-56. CLINICALLY DELIVERABLE DEEP BRAIN STIMULATOR GENERATED ELECTRICAL FIELDS HAVE PROFOUND EFFECTS ON GLIOBLASTOMA MULTIFORME CELL LINES

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees